Metraipolis › archive › dc_ad954afea570

Targeting SUMOylation in glioblastoma: A novel avenue for therapy and biomarker discovery — Europe PMC PMID:41659205

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41659205
DOI
10.1016/j.gendis.2025.101841
License (as archived)
solo-consultazione
Archived
2026-11-10T04:39:19.389Z
SHA-256 of the archived text
23f4d7001d423765b772a2e6713a9e911cc5c39303c499c733e9429c3e4af5f0
Stable URL of this page
https://metraipolis.com/documento/dc_ad954afea570

How to cite

Targeting SUMOylation in glioblastoma: A novel avenue for therapy and biomarker discovery — Europe PMC PMID:41659205 — Europe PMC (en), https://europepmc.org/article/MED/41659205 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad954afea570 (Metraipolis archive dc_ad954afea570, sha256 23f4d7001d423765b772a2e6713a9e911cc5c39303c499c733e9429c3e4af5f0)
BibTeX
@misc{dcad954afea570,
  title = {Targeting SUMOylation in glioblastoma: A novel avenue for therapy and biomarker discovery — Europe PMC PMID:41659205},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41659205},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad954afea570; sha256 23f4d7001d423765b772a2e6713a9e911cc5c39303c499c733e9429c3e4af5f0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41659205. Agents can read the archived copy with the MCP tool read_document.